Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing’s sarcoma

This publication has 40 references indexed in Scilit:

• Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas
  European Journal Of Cancer, 2004
• The association of P‐glycoprotein with response to chemotherapy and clinical outcome in patients with osteosarcoma
  Cancer, 2003
• c-kit Receptor Expression in Ewing’s Sarcoma: Lack of Prognostic Value but Therapeutic Targeting Opportunities in Appropriate Conditions
  Journal of Clinical Oncology, 2003
• Expression of an IGF‐I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells
  International Journal of Cancer, 2002
• EFFECT OF P-GLYCOPROTEIN EXPRESSION ON OUTCOME IN THE EWING FAMILY OF TUMORS
  Pediatric Hematology and Oncology, 2001
• Redundancy of autocrine loops in human osteosarcoma cells
  International Journal of Cancer, 1999
• Enhanced Chemoresistance by Elevation of p185neu Levels in HER-2/neu-Transfected Human Lung Cancer Cells
  JNCI Journal of the National Cancer Institute, 1995
• c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties: Yu D, Wang S-S, Dulski KM, Tsai C-M, Nicolson GL, Hung M-C Department of Tumor Biology, Texas Univ. M. D. Anderson Can. Ctr., Box 79, 1515 Holcombe Blvd., Houston, TX 77030. Cancer Res 1994; 54:3260–3266
  Lung Cancer, 1995
• Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
  Science, 1989
• Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
  Science, 1985